- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/52 - Sulfur atoms
Patent holdings for IPC class C07D 213/52
Total number of patents in this class: 34
10-year publication summary
|
3
|
4
|
2
|
5
|
3
|
2
|
4
|
0
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2315 |
5 |
| PIMCO 2664 Limited | 20 |
5 |
| Enanta Pharmaceuticals, Inc. | 433 |
4 |
| Inflazome Limited | 85 |
3 |
| Atnx Spv, LLC | 39 |
3 |
| University of Southern California | 2123 |
2 |
| Kinex Pharmaceuticals, LLC | 11 |
2 |
| Novartis AG | 10656 |
1 |
| Bayer Cropscience AG | 1997 |
1 |
| Amgen Inc. | 4158 |
1 |
| Henkel AG & Co. KGaA | 10639 |
1 |
| TONIX Pharmaceuticals Holding Corp | 36 |
1 |
| University of Arizona | 16 |
1 |
| Washington University | 1642 |
1 |
| Hangzhou Innogate Pharma Co., Ltd. | 56 |
1 |
| Capacity Bio, Inc. | 3 |
1 |
| Cureverse Incorporated | 3 |
1 |
| Other owners | 0 |